Zeping Zhou

机构：Kunming Medical University · ORCID：0000-0002-7698-7695

发表论文 138 篇 · 总被引 1108 次 · h-index 20

代表论文

• Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials (2025 · Nature Medicine · 被引 9)
• Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
• Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study (2024 · Blood Cancer Journal · 被引 5)
• Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study) (2025 · EClinicalMedicine · 被引 4)
• A retrospective study of risk factors for thrombosis in patients with ITP (2025 · Hematology · 被引 4)
• Chinese guidance for the clinical application of adeno-associated virus vector-based gene therapy for hemophilia B (2025) (2025 · Blood Science · 被引 3)